Is pathologic complete response (pCR) a valid marker of outcome even in large breast cancer?: Clinical results from a neoadjuvant trial using a combination of epirubicin, docetaxel and bevacizumab (PROMIX)
Hatschek, Thomas, Bjoehle, Judith, Lidbrink, Elisabet, Lekberg, Tobias, Loman, Niklas, Vaeppling, Anna von Wachenfeldt, Soederberg, Martin, Einbeigi, Zakaria, Carlsson, Lena, Lindman, Henrik, Fredriksson, Irma, Frisell, Jan, Loefgren, Lars, Ryden, Lisa, Hellstroem, Mats, Fernoe, Marten, Bergh, Jonas
Published in Cancer research (Chicago, Ill.) (2015)
Get full text
Published in Cancer research (Chicago, Ill.) (2015)
Journal Article
Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study
Hall, Per, Ploner, Alexander, Bjöhle, Judith, Huang, Fei, Lin, Chin-Yo, Liu, Edison T, Miller, Lance D, Nordgren, Hans, Pawitan, Yudi, Shaw, Peter, Skoog, Lambert, Smeds, Johanna, Wedrén, Sara, Ohd, John, Bergh, Jonas
Published in BMC medicine (30.06.2006)
Published in BMC medicine (30.06.2006)
Get full text
Journal Article
Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes
Wennmalm, Kristian, Calza, Stefano, Ploner, Alexander, Hall, Per, Bjöhle, Judith, Klaar, Sigrid, Smeds, Johanna, Pawitan, Yudi, Bergh, Jonas
Published in Genes chromosomes & cancer (01.01.2007)
Published in Genes chromosomes & cancer (01.01.2007)
Get full text
Journal Article